Befejeződött1. fázis
A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630, Administered Once Daily via Inhalation, for 2 Weeks, in Adults with Asthma on Medium-to-high Dose Inhaled Corticosteroids and Long-acting Beta-agonists
Key facts
- Where
- Ahrensburg, Berlin, Frankfurt am Main, Luebeck és Mainz, NémetországSee the 5 sites
- Phase
- 1. fázis
Where in Németország
- Velocity Clinical Research Germany GmbHAhrensburg, NémetországNo longer taking part
- Studienpraxis Berlin-Brandenburg Cornelia Seelbinder Und Lennart Schaper GbRBerlin, NémetországNo longer taking part
- IKF Pneumologie GmbH & Co. KGFrankfurt am Main, NémetországNo longer taking part
- Velocity Clinical Research Germany GmbHLuebeck, NémetországNo longer taking part
- IKF Pneumologie GmbH & Co. KGMainz, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AstraZeneca AB
- Trial code
- EU 2024-514213-35-00
- Record updated
- 2025. április 1.